ESR1 and cancer: Activation of PPARγ exerts anti-proliferative, pro-apoptotic, and anti-inflammatory effects by inhibiting cancer-promoting pathways such as the Wnt/β-catenin and modulating estrogen receptor (ER) signaling [87].